APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Treatment Drugs

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Selected research

Industry Research

Cancer Treatment Drugs Industry Research Report 2026

Report ID 173974420521 December 2025151 pages

Choose your research edition.

Industry ResearchCancer Treatment Drugs Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Treatment Drugs Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Treatment Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Treatment Drugs Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.

North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.

Read the full market overview

In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.

Report Scope

This report quantifies the global Cancer Treatment Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cancer Treatment Drugs Market by Company

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co.

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Merck KGaA

Ipsen

AbbVie

Gilead Sciences

Cancer Treatment Drugs Segment by Type

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy (Biologic Therapy)

Others

Cancer Treatment Drugs Segment by Application

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory or Lung Cancer

Others

Cancer Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cancer Treatment Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cancer Treatment Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cancer Treatment Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cancer Treatment Drugs Sales (K Pcs) of Manufacturers (2021-2026) Table 7. Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cancer Treatment Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Cancer Treatment Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cancer Treatment Drugs Average Price (USD/Pcs) of Manufacturers (2021-2026) Table 11. Global Cancer Treatment Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cancer Treatment Drugs, Product Type & Application Table 14. Global Cancer Treatment Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cancer Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Roche Company Information Table 19. Roche Business Overview Table 20. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 21. Roche Cancer Treatment Drugs Product Portfolio Table 22. Roche Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 26. Novartis Cancer Treatment Drugs Product Portfolio Table 27. Novartis Recent Developments Table 28. Celgene Company Information Table 29. Celgene Business Overview Table 30. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 31. Celgene Cancer Treatment Drugs Product Portfolio Table 32. Celgene Recent Developments Table 33. Bristol-Myers Squibb Company Information Table 34. Bristol-Myers Squibb Business Overview Table 35. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 36. Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio Table 37. Bristol-Myers Squibb Recent Developments Table 38. Amgen Company Information Table 39. Amgen Business Overview Table 40. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 41. Amgen Cancer Treatment Drugs Product Portfolio Table 42. Amgen Recent Developments Table 43. Johnson & Johnson Company Information Table 44. Johnson & Johnson Business Overview Table 45. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 46. Johnson & Johnson Cancer Treatment Drugs Product Portfolio Table 47. Johnson & Johnson Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 51. Pfizer Cancer Treatment Drugs Product Portfolio Table 52. Pfizer Recent Developments Table 53. Takeda Company Information Table 54. Takeda Business Overview Table 55. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 56. Takeda Cancer Treatment Drugs Product Portfolio Table 57. Takeda Recent Developments Table 58. Eli Lilly Company Information Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 61. Eli Lilly Cancer Treatment Drugs Product Portfolio Table 62. Eli Lilly Recent Developments Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 66. AstraZeneca Cancer Treatment Drugs Product Portfolio Table 67. AstraZeneca Recent Developments Table 68. Astellas Company Information Table 69. Astellas Business Overview Table 70. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 71. Astellas Cancer Treatment Drugs Product Portfolio Table 72. Astellas Recent Developments Table 73. Merck & Co. Company Information Table 74. Merck & Co. Business Overview Table 75. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 76. Merck & Co. Cancer Treatment Drugs Product Portfolio Table 77. Merck & Co. Recent Developments Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 81. Sanofi Cancer Treatment Drugs Product Portfolio Table 82. Sanofi Recent Developments Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 86. Bayer Cancer Treatment Drugs Product Portfolio Table 87. Bayer Recent Developments Table 88. Biogen Idec Company Information Table 89. Biogen Idec Business Overview Table 90. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 91. Biogen Idec Cancer Treatment Drugs Product Portfolio Table 92. Biogen Idec Recent Developments Table 93. Eisai Company Information Table 94. Eisai Business Overview Table 95. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 96. Eisai Cancer Treatment Drugs Product Portfolio Table 97. Eisai Recent Developments Table 98. Teva Company Information Table 99. Teva Business Overview Table 100. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 101. Teva Cancer Treatment Drugs Product Portfolio Table 102. Teva Recent Developments Table 103. Otsuka Company Information Table 104. Otsuka Business Overview Table 105. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 106. Otsuka Cancer Treatment Drugs Product Portfolio Table 107. Otsuka Recent Developments Table 108. Merck KGaA Company Information Table 109. Merck KGaA Business Overview Table 110. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 111. Merck KGaA Cancer Treatment Drugs Product Portfolio Table 112. Merck KGaA Recent Developments Table 113. Ipsen Company Information Table 114. Ipsen Business Overview Table 115. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 116. Ipsen Cancer Treatment Drugs Product Portfolio Table 117. Ipsen Recent Developments Table 118. AbbVie Company Information Table 119. AbbVie Business Overview Table 120. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 121. AbbVie Cancer Treatment Drugs Product Portfolio Table 122. AbbVie Recent Developments Table 123. Gilead Sciences Company Information Table 124. Gilead Sciences Business Overview Table 125. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 126. Gilead Sciences Cancer Treatment Drugs Product Portfolio Table 127. Gilead Sciences Recent Developments Table 128. Global Cancer Treatment Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Cancer Treatment Drugs Sales by Region (2021-2026) & (K Pcs) Table 130. Global Cancer Treatment Drugs Sales Market Share by Region (2021-2026) Table 131. Global Cancer Treatment Drugs Sales by Region (2027-2032) & (K Pcs) Table 132. Global Cancer Treatment Drugs Sales Market Share by Region (2027-2032) Table 133. Global Cancer Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Cancer Treatment Drugs Revenue Market Share by Region (2021-2026) Table 135. Global Cancer Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Cancer Treatment Drugs Revenue Market Share by Region (2027-2032) Table 137. North America Cancer Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 139. North America Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 140. North America Cancer Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Cancer Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Cancer Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 144. Europe Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 145. Europe Cancer Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Cancer Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Cancer Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 149. Asia Pacific Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 150. Asia Pacific Cancer Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Cancer Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Cancer Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 154. South America Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 155. South America Cancer Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Cancer Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Cancer Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 159. Middle East and Africa Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 160. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Cancer Treatment Drugs Sales by Type (2021-2026) & (K Pcs) Table 163. Global Cancer Treatment Drugs Sales by Type (2027-2032) & (K Pcs) Table 164. Global Cancer Treatment Drugs Sales Market Share by Type (2021-2026) Table 165. Global Cancer Treatment Drugs Sales Market Share by Type (2027-2032) Table 166. Global Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Cancer Treatment Drugs Revenue Market Share by Type (2021-2026) Table 169. Global Cancer Treatment Drugs Revenue Market Share by Type (2027-2032) Table 170. Global Cancer Treatment Drugs Price by Type (2021-2026) & (USD/Pcs) Table 171. Global Cancer Treatment Drugs Price by Type (2027-2032) & (USD/Pcs) Table 172. Global Cancer Treatment Drugs Sales by Application (2021-2026) & (K Pcs) Table 173. Global Cancer Treatment Drugs Sales by Application (2027-2032) & (K Pcs) Table 174. Global Cancer Treatment Drugs Sales Market Share by Application (2021-2026) Table 175. Global Cancer Treatment Drugs Sales Market Share by Application (2027-2032) Table 176. Global Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Cancer Treatment Drugs Revenue Market Share by Application (2021-2026) Table 179. Global Cancer Treatment Drugs Revenue Market Share by Application (2027-2032) Table 180. Global Cancer Treatment Drugs Price by Application (2021-2026) & (USD/Pcs) Table 181. Global Cancer Treatment Drugs Price by Application (2027-2032) & (USD/Pcs) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Cancer Treatment Drugs Distributors List Table 185. Cancer Treatment Drugs Customers List Table 186. Cancer Treatment Drugs Industry Trends Table 187. Cancer Treatment Drugs Industry Drivers Table 188. Cancer Treatment Drugs Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cancer Treatment Drugs Product Image Figure 5. Global Cancer Treatment Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cancer Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Cancer Treatment Drugs Sales (2021-2032) & (K Pcs) Figure 8. Global Cancer Treatment Drugs Average Price (USD/Pcs) & (2021-2032) Figure 9. Chemotherapy Product Image Figure 10. Targeted Therapy Product Image Figure 11. Immunotherapy Product Image Figure 12. Hormonal Therapy (Biologic Therapy) Product Image Figure 13. Others Product Image Figure 14. Blood Cancer Product Image Figure 15. Breast Cancer Product Image Figure 16. Gastrointestinal Cancer Product Image Figure 17. Prostate Cancer Product Image Figure 18. Respiratory or Lung Cancer Product Image Figure 19. Others Product Image Figure 20. Global Cancer Treatment Drugs Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Cancer Treatment Drugs Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Cancer Treatment Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Cancer Treatment Drugs Sales by Region in 2025 Figure 26. Global Cancer Treatment Drugs Revenue by Region in 2025 Figure 27. North America Cancer Treatment Drugs Market Size by Country in 2025 Figure 28. North America Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 29. North America Cancer Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 30. United States Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Cancer Treatment Drugs Market Size by Country in 2025 Figure 34. Europe Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 35. Europe Cancer Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 36. Germany Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific Cancer Treatment Drugs Market Size by Country in 2025 Figure 47. Asia Pacific Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 49. China Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America Cancer Treatment Drugs Market Size by Country in 2025 Figure 58. South America Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 59. South America Cancer Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 60. Brazil Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Cancer Treatment Drugs Market Size by Country in 2025 Figure 64. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 66. Egypt Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Cancer Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Cancer Treatment Drugs Sales Market Share by Type (2021-2032) Figure 72. Global Cancer Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 73. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2021-2032) Figure 74. Global Cancer Treatment Drugs Sales Market Share by Application (2021-2032) Figure 75. Global Cancer Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 76. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2021-2032) Figure 77. Cancer Treatment Drugs Value Chain Figure 78. Cancer Treatment Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Cancer Treatment Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy (Biologic Therapy)
  • Others
Applications
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others
Companies covered
  • Roche
  • Novartis
  • Celgene
  • Bristol-Myers Squibb
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Astellas
  • Merck & Co.
  • Sanofi
  • Bayer
  • Biogen Idec
  • Eisai
  • Teva
  • Otsuka
  • Merck KGaA
  • Ipsen
  • AbbVie
  • Gilead Sciences

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cancer Treatment Drugs Market Size (2021-2032)
  4. 2.2.2 Global Cancer Treatment Drugs Sales (2021-2032)
  5. 2.2.3 Global Cancer Treatment Drugs Market Average Price (2021-2032)
  6. 2.3 Cancer Treatment Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Chemotherapy
  9. 2.3.3 Targeted Therapy
  10. 2.3.4 Immunotherapy
  11. 2.3.5 Hormonal Therapy (Biologic Therapy)
  12. 2.3.6 Others
  13. 2.4 Cancer Treatment Drugs by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Blood Cancer
  16. 2.4.3 Breast Cancer
  17. 2.4.4 Gastrointestinal Cancer
  18. 2.4.5 Prostate Cancer
  19. 2.4.6 Respiratory or Lung Cancer
  20. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cancer Treatment Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cancer Treatment Drugs Sales (K Pcs) of Manufacturers (2021-2026)
  3. 3.3 Global Cancer Treatment Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cancer Treatment Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cancer Treatment Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cancer Treatment Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Cancer Treatment Drugs, Established Date
  9. 3.9 Global Cancer Treatment Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Roche
  2. 4.1.1 Roche Company Information
  3. 4.1.2 Roche Business Overview
  4. 4.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Roche Cancer Treatment Drugs Product Portfolio
  6. 4.1.5 Roche Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Cancer Treatment Drugs Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Celgene
  14. 4.3.1 Celgene Company Information
  15. 4.3.2 Celgene Business Overview
  16. 4.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Celgene Cancer Treatment Drugs Product Portfolio
  18. 4.3.5 Celgene Recent Developments
  19. 4.4 Bristol-Myers Squibb
  20. 4.4.1 Bristol-Myers Squibb Company Information
  21. 4.4.2 Bristol-Myers Squibb Business Overview
  22. 4.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio
  24. 4.4.5 Bristol-Myers Squibb Recent Developments
  25. 4.5 Amgen
  26. 4.5.1 Amgen Company Information
  27. 4.5.2 Amgen Business Overview
  28. 4.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Amgen Cancer Treatment Drugs Product Portfolio
  30. 4.5.5 Amgen Recent Developments
  31. 4.6 Johnson & Johnson
  32. 4.6.1 Johnson & Johnson Company Information
  33. 4.6.2 Johnson & Johnson Business Overview
  34. 4.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Johnson & Johnson Cancer Treatment Drugs Product Portfolio
  36. 4.6.5 Johnson & Johnson Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Cancer Treatment Drugs Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 Takeda
  44. 4.8.1 Takeda Company Information
  45. 4.8.2 Takeda Business Overview
  46. 4.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Takeda Cancer Treatment Drugs Product Portfolio
  48. 4.8.5 Takeda Recent Developments
  49. 4.9 Eli Lilly
  50. 4.9.1 Eli Lilly Company Information
  51. 4.9.2 Eli Lilly Business Overview
  52. 4.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Eli Lilly Cancer Treatment Drugs Product Portfolio
  54. 4.9.5 Eli Lilly Recent Developments
  55. 4.10 AstraZeneca
  56. 4.10.1 AstraZeneca Company Information
  57. 4.10.2 AstraZeneca Business Overview
  58. 4.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 AstraZeneca Cancer Treatment Drugs Product Portfolio
  60. 4.10.5 AstraZeneca Recent Developments
  61. 4.11 Astellas
  62. 4.11.1 Astellas Company Information
  63. 4.11.2 Astellas Business Overview
  64. 4.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Astellas Cancer Treatment Drugs Product Portfolio
  66. 4.11.5 Astellas Recent Developments
  67. 4.12 Merck & Co.
  68. 4.12.1 Merck & Co. Company Information
  69. 4.12.2 Merck & Co. Business Overview
  70. 4.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Merck & Co. Cancer Treatment Drugs Product Portfolio
  72. 4.12.5 Merck & Co. Recent Developments
  73. 4.13 Sanofi
  74. 4.13.1 Sanofi Company Information
  75. 4.13.2 Sanofi Business Overview
  76. 4.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sanofi Cancer Treatment Drugs Product Portfolio
  78. 4.13.5 Sanofi Recent Developments
  79. 4.14 Bayer
  80. 4.14.1 Bayer Company Information
  81. 4.14.2 Bayer Business Overview
  82. 4.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bayer Cancer Treatment Drugs Product Portfolio
  84. 4.14.5 Bayer Recent Developments
  85. 4.15 Biogen Idec
  86. 4.15.1 Biogen Idec Company Information
  87. 4.15.2 Biogen Idec Business Overview
  88. 4.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Biogen Idec Cancer Treatment Drugs Product Portfolio
  90. 4.15.5 Biogen Idec Recent Developments
  91. 4.16 Eisai
  92. 4.16.1 Eisai Company Information
  93. 4.16.2 Eisai Business Overview
  94. 4.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Eisai Cancer Treatment Drugs Product Portfolio
  96. 4.16.5 Eisai Recent Developments
  97. 4.17 Teva
  98. 4.17.1 Teva Company Information
  99. 4.17.2 Teva Business Overview
  100. 4.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Teva Cancer Treatment Drugs Product Portfolio
  102. 4.17.5 Teva Recent Developments
  103. 4.18 Otsuka
  104. 4.18.1 Otsuka Company Information
  105. 4.18.2 Otsuka Business Overview
  106. 4.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Otsuka Cancer Treatment Drugs Product Portfolio
  108. 4.18.5 Otsuka Recent Developments
  109. 4.19 Merck KGaA
  110. 4.19.1 Merck KGaA Company Information
  111. 4.19.2 Merck KGaA Business Overview
  112. 4.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Merck KGaA Cancer Treatment Drugs Product Portfolio
  114. 4.19.5 Merck KGaA Recent Developments
  115. 4.20 Ipsen
  116. 4.20.1 Ipsen Company Information
  117. 4.20.2 Ipsen Business Overview
  118. 4.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Ipsen Cancer Treatment Drugs Product Portfolio
  120. 4.20.5 Ipsen Recent Developments
  121. 4.21 AbbVie
  122. 4.21.1 AbbVie Company Information
  123. 4.21.2 AbbVie Business Overview
  124. 4.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 AbbVie Cancer Treatment Drugs Product Portfolio
  126. 4.21.5 AbbVie Recent Developments
  127. 4.22 Gilead Sciences
  128. 4.22.1 Gilead Sciences Company Information
  129. 4.22.2 Gilead Sciences Business Overview
  130. 4.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Gilead Sciences Cancer Treatment Drugs Product Portfolio
  132. 4.22.5 Gilead Sciences Recent Developments
5 Global Cancer Treatment Drugs Market Scenario by Region
  1. 5.1 Global Cancer Treatment Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cancer Treatment Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Cancer Treatment Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Cancer Treatment Drugs Sales by Region: 2027-2032
  5. 5.3 Global Cancer Treatment Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Cancer Treatment Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Cancer Treatment Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Cancer Treatment Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cancer Treatment Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Cancer Treatment Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cancer Treatment Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cancer Treatment Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Cancer Treatment Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cancer Treatment Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cancer Treatment Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cancer Treatment Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cancer Treatment Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cancer Treatment Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Cancer Treatment Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Cancer Treatment Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Cancer Treatment Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Cancer Treatment Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cancer Treatment Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Cancer Treatment Drugs Sales by Type (2021-2032) & (K Pcs)
  3. 6.1.2 Global Cancer Treatment Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cancer Treatment Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Cancer Treatment Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cancer Treatment Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cancer Treatment Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cancer Treatment Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Cancer Treatment Drugs Sales by Application (2021-2032) & (K Pcs)
  3. 7.1.2 Global Cancer Treatment Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cancer Treatment Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Cancer Treatment Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cancer Treatment Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cancer Treatment Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cancer Treatment Drugs Value Chain Analysis
  2. 8.1.1 Cancer Treatment Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cancer Treatment Drugs Production Mode & Process
  5. 8.2 Cancer Treatment Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cancer Treatment Drugs Distributors
  8. 8.2.3 Cancer Treatment Drugs Customers
9 Global Cancer Treatment Drugs Analyzing Market Dynamics
  1. 9.1 Cancer Treatment Drugs Industry Trends
  2. 9.2 Cancer Treatment Drugs Industry Drivers
  3. 9.3 Cancer Treatment Drugs Industry Opportunities and Challenges
  4. 9.4 Cancer Treatment Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst